179 related articles for article (PubMed ID: 20932224)
1. Oral salmon calcitonin--pharmacology in osteoporosis.
Henriksen K; Bay-Jensen AC; Christiansen C; Karsdal MA
Expert Opin Biol Ther; 2010 Nov; 10(11):1617-29. PubMed ID: 20932224
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
Bandeira L; Lewiecki EM; Bilezikian JP
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.
Karsdal MA; Henriksen K; Bay-Jensen AC; Molloy B; Arnold M; John MR; Byrjalsen I; Azria M; Riis BJ; Qvist P; Christiansen C
J Clin Pharmacol; 2011 Apr; 51(4):460-71. PubMed ID: 20660294
[TBL] [Abstract][Full Text] [Related]
4. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.
Plosker GL; McTavish D
Drugs Aging; 1996 May; 8(5):378-400. PubMed ID: 8935399
[TBL] [Abstract][Full Text] [Related]
5. Salmon calcitonin: a review of current and future therapeutic indications.
Chesnut CH; Azria M; Silverman S; Engelhardt M; Olson M; Mindeholm L
Osteoporos Int; 2008 Apr; 19(4):479-91. PubMed ID: 18071651
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin.
Silverman SL
Am J Med Sci; 1997 Jan; 313(1):13-6. PubMed ID: 9001161
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
[TBL] [Abstract][Full Text] [Related]
9. Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy.
Peichl P; Rintelen B; Kumpan W; Bröll H
Gynecol Endocrinol; 1999 Feb; 13(1):7-14. PubMed ID: 10368793
[TBL] [Abstract][Full Text] [Related]
10. Oral calcitonin.
Maricic MJ
Curr Osteoporos Rep; 2012 Mar; 10(1):80-5. PubMed ID: 22281725
[TBL] [Abstract][Full Text] [Related]
11. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
Wang SX; Li H
Chin Med J (Engl); 2008 Jul; 121(14):1280-4. PubMed ID: 18713548
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin therapy in osteoporosis.
Muñoz-Torres M; Alonso G; Raya MP
Treat Endocrinol; 2004; 3(2):117-32. PubMed ID: 15743107
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin intranasal--unigene: Salcatonin intranasal--unigene.
Drugs R D; 2004; 5(2):90-3. PubMed ID: 15293868
[TBL] [Abstract][Full Text] [Related]
14. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
Wang SX; Li H
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):387-90. PubMed ID: 18581891
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality.
Karsdal MA; Henriksen K; Arnold M; Christiansen C
BioDrugs; 2008; 22(3):137-44. PubMed ID: 18481897
[TBL] [Abstract][Full Text] [Related]
16. Nasal calcitonin.
Silverman SL
Endocrine; 1997 Apr; 6(2):199-202. PubMed ID: 9225136
[TBL] [Abstract][Full Text] [Related]
17. Calcitonins and osteoporosis.
Gennari C; Agnusdei D
Br J Clin Pract; 1994; 48(4):196-200. PubMed ID: 7917799
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.
Karsdal MA; Byrjalsen I; Henriksen K; Riis BJ; Lau EM; Arnold M; Christiansen C
Osteoarthritis Cartilage; 2010 Feb; 18(2):150-9. PubMed ID: 19747581
[TBL] [Abstract][Full Text] [Related]
19. Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
Mango D; Ricci S; Manna P; Natili G; Dell'Acqua S
Minerva Endocrinol; 1993 Sep; 18(3):115-21. PubMed ID: 8183178
[TBL] [Abstract][Full Text] [Related]
20. [Salmon calcitonin in the treatment of osteoporosis].
Payer J; Killinger Z; Ondrejka P
Vnitr Lek; 1999 Aug; 45(8):476-9. PubMed ID: 11045148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]